LGM Pharma Acquires Sannova Analytical to Expand Testing Services
1 report, 1 independent
Updated Oct 22
AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
LGM Pharma completed the acquisition of Sannova Analytical on October 22, 2026. Sannova Analytical is a contract research laboratory headquartered in Somerset, N.J. The acquisition integrates Sannova's services, including Good Laboratory Practice (GLP) bioanalysis and genotoxic impurity testing, into LGM Pharma's existing analytical testing business. Sannova will continue to operate under its own name and management team.
Why it matters
The acquisition expands LGM Pharma’s analytical testing services by adding specialized capabilities like nitrosamine impurity testing and extractables evaluations. This move supports LGM Pharma's strategy to build a U.S.-based analytical services platform alongside its API sourcing business.
Who's involved
- SannovaContract research laboratory acquired by LGM Pharma
Keep exploring
The entities involved
-
Sannova
Nothing else this week.